Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications by Alina Mihaela Leustean, Manuela Ciocoiu, Anca Sava, Claudia Florida Costea, Mariana Floria, Claudia Cristina Tarniceriu, Daniela Maria Tanase

“…Key factors that cause cardiovascular disease in people with diabetes include hyperglycemia, dyslipidemia, obesity, insulin resistance, inflammation, hypertension, autonomic dysfunction, and decreased vascular response capacity. …”
Get full text

Anthropometric Indices of Obesity and the Prediction of Cardiovascular Risk Factors in an Iranian Population by Mohsen Azimi–Nezhad, Majid Ghayour–Mobarhan, Mohammad Safarian, Habibollah Esmailee, Seyed Mohammad Reza Parizadeh, Maryam Rajabi-Moghadam, Arezoo Gholami, Mohammad Reza Oladi, Gordon A. Ferns

Get full text

Risk of Cardiovascular Diseases in Diabetes Mellitus and Serum Concentration of Asymmetrical Dimethylarginine by Seema L. Jawalekar, Aarti Karnik, Anil Bhutey

“…ADMA is an emerging independent risk marker for future CVD (cardiovascular disease) events.…”
Get full text

Association of Inflammatory Markers/Cytokines with Cardiovascular Risk Manifestation in Patients with Endometriosis by Uzma Rafi, Shaaf Ahmad, Syeda Shazia Bokhari, Muhammad Amir Iqbal, Amna Zia, Muhammad Amjad Khan, Nabila Roohi

“…This study is aimed at determining the association of inflammatory markers and proinflammatory cytokines with cardiovascular risk manifestation in women with endometriosis as compared to healthy controls. …”
Get full text

Roles of the Chemokine System in Development of Obesity, Insulin Resistance, and Cardiovascular Disease by Longbiao Yao, Oana Herlea-Pana, Janet Heuser-Baker, Yitong Chen, Jana Barlic-Dicen

“…This low-grade chronic inflammation is thought to link obesity to insulin resistance and the associated comorbidities of metabolic syndrome such as dyslipidemia and hypertension, which increase risk of type 2 diabetes and cardiovascular disease. In this review, we focus on and discuss members of the chemokine system for which there is clear evidence of participation in the development of obesity and obesity-induced pathologies.…”
Get full text

Pharmacological Evaluation of the Effects of Phenylcarbamic Acid Derivatives on Cardiovascular Functions in Rats by Kralova Eva, Racanska Eva, Vicenova Anna, Boselova Iveta, Malik Ivan, Stankovicova Tatiana

“…Four phenylcarbamic acid derivatives, (1-(4-fluorophenyl)- 4-[3-(4-methoxyphenylcarbamoyloxy)-2-hydroxypropyl]piperazinium chloride (1), (1-(2-methylphenyl)-4-[3-(4-methoxyphenylcarbamoyloxy)- 2-hydroxypropyl]piperazinium chloride) (2), (1-(2-methylphenyl)-4-[3-(4-ethoxyphenylcarbamoyloxy)- 2-hydroxypropyl]piperazinium chloride) (3) and (1-(3-trifluoromethylphenyl)-4-[3-(4-methoxyphenylcarbamoyloxy)- 2-hydroxypropyl]piperazinium chloride) (4) were investigated for their ability to affect various cardiovascular functions and to establish their chemical structure-biological activity relationship. …”
Get full text

Stress, sleep, and cardiovascular risk in police officers: A scoping review by Nicola MAGNAVITA, Francesco CHIRICO, Sergio GARBARINO, Fabrizio CIPRANI

Get full text

PPARs, Cardiovascular Metabolism, and Function: Near- or Far-from-Equilibrium Pathways by Yves Lecarpentier, Victor Claes, Jean-Louis Hébert

“…Peroxisome proliferator-activated receptors (PPAR α, β/δ and γ) play a key role in metabolic regulatory processes and gene regulation of cellular metabolism, particularly in the cardiovascular system. Moreover, PPARs have various extra metabolic roles, in circadian rhythms, inflammation and oxidative stress. …”
Get full text

Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros by Konstantinos Makrilakis, Stavros Liatis

“…Although it frequently coexists with other cardiovascular disease (CVD) risk factors, it confers an increased risk for CVD events on its own. …”
Get full text

Cardiovascular Risk in Chronic Kidney Disease: Role of the Sympathetic Nervous System by Jeanie Park

“…Patients with chronic kidney disease are at significantly increased risk for cardiovascular disease and sudden cardiac death. One mechanism underlying increased cardiovascular risk in patients with renal failure includes overactivation of the sympathetic nervous system (SNS). …”
Get full text

Lifelong cardiovascular care in Turner syndrome: two cases with review of literature by Shun Moriguchi, Yuri Mukoyama, Fumihiko Takizawa, Atsushi Ogawa, Tetsushi Ogawa, Junko Ito, Yukishige Yanagawa, Chinatsu Komiyama, Rieko Niitsu, Tsuyoshi Isojima

Subjects: Get full text

System of psycho-therapeutics influences in patients admitted to hospital with cardiovascular diseases. by Teresa Rodríguez Rodríguez, Juan José Navarro López

Subjects: Get full text

Understanding integrative approach of translational bioinformatics on cardiovascular disease: Myocardial Ischemia by Yeswanth Ranganathan, Saayaa Nazar, Ravi Shankar Krishnan, Yuvaraj Dinakarkumar, Vijayalakshmi Varadarajan, Lenita Sebastian, Brindha Rethinam

“…Abstract Background Myocardial ischemia is a significant problem in cardiovascular health caused by the obstruction or constriction of coronary arteries, resulting in diminished blood supply to the heart muscle. …”
Get full text

Association between chronic fatigue syndrome/myalgic encephalomyelitis and cardiovascular disease by Mawulorm K. I. Denu, Ritika Revoori, Cherita Eghan, Fredrick Larbi Kwapong, Andrew Hillman, Cornelius A. Normeshie, Kofi Poku Berko, Emily L. Aidoo, Maame Araba E. Buadu

Subjects: Get full text

Obstetric Considerations in a Rare Cardiovascular Catastrophe Needing Multidisciplinary Care by Neeta Singh, Debjyoti Karmakar, V. Devagorou, Rajnish Tiwari, Sunesh Kumar

“…Cardiovascular emergencies especially aortic dissections are rare in pregnancy. …”
Get full text

Monocyte/Lymphocyte Ratio and Cardiovascular Disease Mortality in Peritoneal Dialysis Patients by Yueqiang Wen, Xiaojiang Zhan, Niansong Wang, FenFen Peng, Xiaoran Feng, Xianfeng Wu

“…The monocyte-to-lymphocyte ratio (MLR), as a new marker of the systemic inflammatory response, is associated with cardiovascular disease (CVD) mortality in the general population and hemodialysis patients. …”
Get full text

Cardiovascular response of students to physical exertion using the 'Trunk Flexion Test' by Iryna Ivanyshyn, Krzysztof Prusik, Daria Piatnytska, Victoriia Spuziak

“…The aim of the study is to assess the cardiovascular system response of students to physical exercise using the 'Trunk Flexion Test'. …”
Get full text

Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide prospective cohort study by Gaoshu Zheng, Jijie Jin, Fei Wang, Qianrong Zheng, Jiaxin Shao, Jiangnan Yao, Pan Huang, Hao Zhou, Jianghua Zhou

Subjects: Get full text

Impact of a cardio‐oncology unit on prevention of cardiovascular events in cancer patients by Alessandra Cuomo, Valentina Mercurio, Gilda Varricchi, Maria Rosaria Galdiero, Francesca Wanda Rossi, Antonio Carannante, Grazia Arpino, Luigi Formisano, Roberto Bianco, Chiara Carlomagno, Carmine De Angelis, Mario Giuliano, Elide Matano, Marco Picardi, Domenico Salvatore, Ferdinando De Vita, Erika Martinelli, Carminia Maria Della Corte, Floriana Morgillo, Michele Orditura, Stefania Napolitano, Teresa Troiani, Carlo G. Tocchetti

Subjects: Get full text

Protective Role of the ACE2/Ang-(1–9) Axis in Cardiovascular Remodeling by María Paz Ocaranza, Jorge E. Jalil

“…Despite reduction in cardiovascular (CV) events and end-organ damage with the current pharmacologic strategies, CV disease remains the primary cause of death in the world. …”
Get full text